3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Skin Neoplasms
1
Dysplastic Nevus Syndrome
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Interventions
aldesleukin
16
Cyclophosphamide
14
fludarabine phosphate
11
Interleukin-2
11
fludarabine
10
Nivolumab
7
pembrolizumab
5
cemiplimab
5
Ipilimumab
5
Temozolomide
4
Fluorouracil
4
Aminolevulinic Acid
4
sonidegib
3
Surgical Procedures, Operative
3
Radiotherapy
3
zanolimumab
2
trametinib
2
talabostat
2
montanide ISA 51
2
dabrafenib
2
Whole-Body Irradiation
2
Tablets
2
Semaxinib
2
Radiation
2
Petrolatum
2
Peptides
2
MART-1 Antigen
2
Gefitinib
2
Eflornithine
2
Cisplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Skin Neoplasms
×
Sutures
×
Clear all
NCT00586040
2009-04-10
PTB
Massachusetts General Hospital
Phase 2
Completed
40 enrolled